Immunization with Toscana virus N-Gc proteins protects mice against virus challenge

Envelope glycoprotein; Nucleocapsid protein; Toscana virus; Vaccine; CD8+ T lymphocyte; Phlebovirus; T lymphocyte; Animals; Antibodies, Viral; CD8-Positive T-Lymphocytes; Cells, Cultured; Cytotoxicity Tests, Immunologic; Female; Humans; Immunization; Immunization Schedule; Injections, Intraperitoneal; Interferon Type II; Mice; Mice, Inbred BALB C; Neutralization Tests; Nucleocapsid Proteins; Phlebotomus Fever; Sandfly fever Naples virus; Spleen; Vaccines, Synthetic; Viral Envelope Proteins; Viral Vaccines; Animalia; Mus

Abstract :

[en] Toscana virus (TOSV) is an emerging virus, circulating in the Mediterranean area, that is responsible for aseptic meningitis, meningoencephalitis, and encephalitis. The development of a vaccine that could provide complete protection from TOSV infection is needed. In this study we investigated the capacity of TOSV structural proteins, nucleocapsid protein N and the two Gc and Gn glycoproteins, produced as recombinant proteins, in an animal model. In particular, we investigated their role in inducing specific and protective immune responses against virus infection. Mice were immunized intraperitoneally using TOSV antigens singly or in combination. The results show that only the N-Gc combination was able to protect 100% of animals from a lethal challenge with a neurovirulent strain of TOSV. This potential vaccine induces high serum antibody titres with neutralizing activity and it is safe for animals. Moreover, immunization induces a virus specific cell-mediated immune response, in particular a CD8+ T cell response associated with a marked expression of interferon gamma. These results indicate that the N + Gc viral antigen combination could be useful for future development of a vaccine controlling the spread of this emerging virus that could pose a new threat for humans. © 2008 Elsevier Inc. All rights reserved.

Disciplines :

Microbiology

Author, co-author :

Gori Savellini, G.; Department of Molecular Biology, Section of Microbiology, University of Siena, V.le Bracci, 1, Siena, Italy

Di Genova, G.; Department of Molecular Biology, Section of Microbiology, University of Siena, V.le Bracci, 1, Siena, Italy

Terrosi, C.; Department of Molecular Biology, Section of Microbiology, University of Siena, V.le Bracci, 1, Siena, Italy

Di Bonito, P.; Department of Infectious, Parasitic and Immune Mediated Diseases, Istituto Superiore di Sanità, V.le Regina Elena, Roma, Italy

Giorgi, C.; Department of Infectious, Parasitic and Immune Mediated Diseases, Istituto Superiore di Sanità, V.le Regina Elena, Roma, Italy

Valentini, M.; Department of Molecular Biology, Section of Microbiology, University of Siena, V.le Bracci, 1, Siena, Italy

Docquier, Jean-Denis ; Université de Liège - ULiège > Département des sciences de la vie > Centre d'ingénierie des protéines

Cusi, M. G.; Department of Molecular Biology, Section of Microbiology, University of Siena, V.le Bracci, 1, Siena, Italy

Language :

English

Title :

Immunization with Toscana virus N-Gc proteins protects mice against virus challenge

Publication date :

2008

Journal title :

Virology

ISSN :

0042-6822

eISSN :

1096-0341

Publisher :

Elsevier, Atlanta, United States - California

Volume :

375

Issue :

Pages :

521-528

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 23 November 2020

Statistics

Number of views

43 (1 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Accardi L., Gro M.C., Di Bonito P., and Giorgi C. Toscana virus genomic L segment: molecular cloning, coding strategy and amino acid sequence in comparison with other negative strand RNA viruses. Virus Res. 27 (1993) 119-131
Arikawa J., Schmaljohn A.L., Dalrymple J.M., and Schmaljohn C.S. Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J. Gen. Virol. 70 (1989) 615-624
Bishop D.H.L. Bunyaviridae and their replication. I. Bunyaviridae. In: Fields B.N., Knipe D.M., Chanock R.M., Hirsch M.S., Melnick J.L., Monath T.P., and Roizman B. (Eds). Fields' Virology (1990), Raven, New York 1155-1173
Braito A., Corbisiero R., Corradini S., Marchi B., Sancasciani N., Fiorentini C., and Ciufolini M.G. Evidence of Toscana virus infections without central nervous system involvement: a serological study. Eur. J. Epidemiol. 13 (1997) 761-764
Braito A., Ciufolini M.G., Pippi L., Corbisiero R., Fiorentini C., Gistri A., and Toscano L. Phlebotomus-transmitted Toscana virus infections of the central nervous system: a seven-year experience in Tuscany. Scand. J. Infect. Dis. 30 (1998) 505-508
Braito A., Corbisiero R., Corradini S., Fiorentini C., and Ciufolini M.G. Toscana virus infections of the central nervous system in children: a report of 14 cases. J. Pediatr. 132 (1998) 144-148
Calisher C.H., Weinberg A.N., Muth D.J., and Lazuick J.S. Toscana virus infection in United States citizen returning from Italy. Lancet 17 (1987) 165-166
Cusi M.G., Valensin P.E., Donati M., and Valassina M. Neutralization of Toscana virus is partially mediated by antibodies to the nucleocapsid protein. J. Med. Virol. 63 (2001) 72-75
Cusi M.G., Valentini M., Valensin P.E., and Valassina M. Immune response to the neurotropic Toscana virus infection: preliminary data. 1st SIV International Workshop on Neurovirology (2002) Alghero, June 23-25, Italy
Cusi M.G., Gori Savellini G., Terrosi C., Di Genova G., Valassina M., Valentini M., Bartolommei S., and Miracco C. Development of a mouse model for the study of Toscana virus pathogenesis. Virology 333 (2005) 66-73
Di Bonito P., Mochi S., Gro M.C., Fortini D., and Giorgi C. Organization of the M genomic segment of Toscana phlebovirus. J. Gen. Virol. 76 (1997) 77-81
Di Bonito P., Bosco S., Mochi S., Accardi L., Ciufolini M.G., Nicoletti L., and Giorgi C. Human antibody response to Toscana virus glycoproteins expressed by recombinant baculovirus. J. Med.Virol. 68 (2002) 615-619
Dionisio D., Valassina M., Ciufolini M.G., Vivarelli A., Esperti F., Cusi M.G., Mazzoli F., and Lupi C. Encephalitis without meningitis due to sandfly fever virus serotype Toscana. Clin. Infect. Dis. 32 (2001) 1241-1248
Dobler G., Treib J., Haass A., Frosner G., Woesner R., and Schimrigk K. Toscana virus infection in German travellers returning from the Mediterranean. Infection 25 (1997) 325
Echevarria J.M., De Ory F., Guisasola M.E., Sanchez-Seco M.P., Tenorio A., Lozano A., Cordoba J., and Gobernado M. Acute meningitis due to Toscana virus infection among patients from both the Spanish Mediterranean region and the region of Madrid. J. Clin. Virol. 26 (2003) 79-84
Ehrnst A., Peters C.J., Niklasson B., Svedmyr A., and Holmgren B. Neurovirulent Toscana virus (a sandfly fever virus) in Swedish man after visit to Portugal. Lancet 25 (1985) 1212-1213
Eitrem R., Vene S., and Niklasson B. Incidence of sand fly fever among Swedish United Nations soldiers on Cyprus during 1985. Am. J. Trop. Med. Hyg. 43 (1990) 207-211
Eitrem R., Niklasson B., and Weiland O. Sandfly fever among Swedish tourists (1991). Scand. J. Infect. Dis. 23 (1991) 451-457
Eitrem R., Stylianou M., and Niklasson B. High prevalence rates of antibody to three sandfly fever viruses (Sicilian, Naples and Toscana) among Cypriots. Epidemiol. Infect. 107 (1991) 685-691
Elliot R.M., Schmaljohn C.S., and Collett M.S. Bunyaviridae genome structure and gene expression. Curr. Top. Microbiol. Immunol. 169 (1991) 91-141
Endris R.G., and Perkins P.V. Transmission of Toscana virus by sandflies in Italy. Lancet 4 (1987) 808-809
Giorgi C., Accardi L., Nicoletti L., Gro M.C., Takehara K., Hilditch C., Morikawa S., and Bishop D.H. Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses. Virology 180 (1991) 738-753
Gonzales-Scarano F., and Nathanson N. In: Fields B.N., Knipe D.M., et al. (Eds). Virology (1990), Raven Press, New York 1195-1228
Gonzalez-Scarano F., Shope R.E., Calisher C.E., and Nathanson N. Characterization of monoclonal antibodies against GN and N proteins of La Crosse and Tahyna, two California serogroup bunyaviruses. Virology 120 (1982) 42-53
Grady L., and Kinch W. Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity. J. Gen. Virol. 66 (1985) 2773-2776
Gro M.C., Di Bonito P., Fortini D., Mochi S., and Giorgi C. Completion of molecular characterization of Toscana phlebovirus genome: nucleotide sequence, coding strategy of M genomic segment and its amino acid sequence comparison to other phleboviruses. Virus Res. 51 (1997) 81-91
Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53 (1958) 457-481
Meegan J.M., and Bailey C.L. Rift Valley fever. In: Monath T.P. (Ed). The Arboviruses: Epidemiology and Ecology (1988), CRC Press, Boca Raton, FL 51-76
Nicoletti L., Verani P., Caciolli S., Ciufolini M.G., Renzi A., Bartolozzi D., Paci P., Leoncini F., Padovani P., and Traini E. Central nervous system involvement during infection by Phlebovirus toscana of residents in natural foci in central Italy (1977-1988). Am. J. Trop. Med. Hyg. 45 (1991) 429-434
Portolani M., Sabbatini A.M., Beretti F., Gennari W., Tamassia M.G., and Pecorari M. Symptomatic infections by Toscana virus in the Modena province in the triennium 1999-2001. New Microbiol. 25 (2002) 485-488
Saluzzo J.F., Anderson Jr. G.W., Hodgson L.A., Digoutte J.P., and Smith J.F. Antigenic and biological properties of Rift Valley fever virus isolated during the 1987 Mauritanian epidemic. Res. Virol. 140 (1989) 155-164
Saluzzo J.F., Anderson Jr. G.W., Smith J.F., Fontenille D., and Coulanges P. Biological and antigenic relationship between Rift Valley fever virus strains isolated in Egypt and Madagascar. Trans. R. Soc. Trop. Med. Hyg. 83 (1989) 701
Schwarz T.F., and Jager G. Serosurvey and laboratory diagnosis of imported sandfly fever virus, serotype Toscana, infection in Germany. Epidemiol. Infect. 114 (1995) 501-510
Schwarz T.F., Gilch S., and Jager G. Travel-related Toscana virus infection. Lancet 25 (1993) 803-804
Soldateschi D., Dal Maso G.M., Valassina M., Santini L., Bianchi S., and Cusi M.G. Laboratory diagnosis of Toscana virus infection by enzyme immunoassay with recombinant viral nucleoprotein. J. Clin. Microbiol. 37 (1999) 649-652
Tesh R.B. Phlebotomus fevers. In: Monath T.P. (Ed). The Arboviruses: Epidemiology and Ecology (1988), CRC Press, Boca Raton 15-27
Tesh R.B., Saidi S., Gajdamovic J.J., Rodhain F., and Vesenjak-Hirjan J. Serological studies on the epidemiology of sandfly fever in the Old World. Bull. World Health Organ 54 (1976) 663-674
Valassina M., Cuppone A.M., Bianchi S., Santini L., and Cusi M.G. Evidence of Toscana virus variants circulating in Tuscany, Italy, during the summers of 1995 to 1997. J. Clin. Microbiol. 36 (1998) 2103-2104
Valassina M., Soldateschi D., Dal Maso G.M., Santini L., Bianchi S., Valensin P.E., and Cusi M.G. Diagnostic potential of Toscana virus N protein expressed in Escherichia coli. J. Clin. Microbiol. 36 (1998) 3170-3172
Valassina M., Meacci F., Valensin P.E., and Cusi M.G. Detection of neurotropic viruses circulating in Tuscany: the incisive role of Toscana virus. J. Med. Virol. 60 (2000) 86-90
Valassina M., Valentini M., Pugliese A., Valensin P.E., and Cusi M.G. Serological survey of toscana virus infections in a high-risk population in Italy. Clin. Diagn. Lab. Immunol. 10 (2003) 483-484
Wallace D.B., Ellis C.E., Espach A., Smith S.J., Greyling R.R., and Viljoen G.J. Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. Vaccine 24 (2006) 7181-7189
Workman P., Twentyman P., Balkwill F., Balmain A., Chaplin D., Double J., Embleton J., Newell D., Raymond R., Stables J., Stephens T., and Wallace J. United Kingdom co- ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition). Br. J. Cancer 77 (1998) 1-10